CardieX Limited (CDEXF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
As of 09:57AM EDT. Market open.
Loading interactive chart…
- Simply Wall St.
CardieX Full Year 2023 Earnings: AU$0.15 loss per share (vs AU$0.12 loss in FY 2022)
CardieX ( ASX:CDX ) Full Year 2023 Results Key Financial Results Revenue: AU$5.95m (up 26% from FY 2022). Net loss...
- PR Newswire
ATCOR Medical Enters into Partnership Agreement with Datacubed Health to Increase Patient Retention and Engagement in Decentralized Clinical Trials
ATCOR Medical, subsidiary of CardieX and developer of innovative medical devices and digital solutions to personalize healthcare and improve clinical trial patient outcomes, today announces it has entered into a partnership agreement with Datacubed Health, a leading eClinical technology company, advancing access to healthcare for everyone, everywhere.
- PR Newswire
CardieX Selected for Medtech Innovator's 2023 Accelerator Cohort
Cardiovascular health technology company, CardieX Limited, is pleased to announce it has been selected as part of MedTech Innovator's 2023 Accelerator Cohort.
© 2024 Yahoo. All rights reserved.